Becoming a strong regional player and the first partnering choice
Expanding the product portfolio will strenghten the growth potential.
Grow organically in selected new markets to become a strong regional player with stable, geographically diversified revenues by:
Maintain the Company’s position as a leading Bulgarian pharmaceutical manufacturer with high quality affordable products and improve existing products.
Double the capacity of the lyophilic production with the construction of the new plant in Sofia. Prepare for pending Tabex registration with the FDA with the new extraction facility to be built in Kazanlak.
Further consolidate and integrate the Group to optimize its cost structure, control entirely the production chain and benefit from potential synergies.